Literature DB >> 19771467

Chronic schistosomiasis japonica is an independent adverse prognostic factor for survival in hepatocellular carcinoma patients who have undergone hepatic resection: clinicopathological and prognostic analysis of 198 consecutive patients.

Masanori Matsuda1, Hideki Fujii.   

Abstract

BACKGROUND: The present study was carried out to clarify the clinicopathological features of hepatocellular carcinoma (HCC) patients with chronic schistosomiasis japonica (SJ) who underwent hepatic resection. Furthermore, we also analyzed the impact of chronic SJ on survival after hepatic resection.
METHODS: During the last 10 years in our department, 198 patients have undergone hepatic resection for HCC. Forty-four patients were diagnosed as having chronic SJ by histological examination. Clinicopathological features and survival were retrospectively analyzed.
RESULTS: Age in the SJ group was significantly higher than in the non-SJ group. In the SJ group, positivity to HBsAg (hepatitis B surface antigen) was significantly lower than in the non-SJ group, and patients more often developed intrahepatic cholangiocellular carcinoma (or cholangiolocellular carcinoma) than in the non-SJ group. Greatest tumor dimension in the SJ group was significantly larger than in the non-SJ group. Univariate analysis revealed that chronic SJ, prothrombin time 80% or less and Child-Pugh B, des-gamma-carboxyprothrombin (DCP) level >40 milli-arbitrary units (mAU)/ml, tumor diameter of more than 5.0 cm, multiple tumors, vascular invasion, intrahepatic metastasis, advanced T stage (T2-4), and non-curative resection were associated with significantly worse overall survival. By multivariate analysis, chronic SJ, Child-Pugh B, advanced T stage, and non-curative resection were independent predictors of the adverse overall survival of HCC patients after hepatic resection.
CONCLUSIONS: Patients with chronic SJ were older, had larger HCC, and were more often complicated by cholangiocellular carcinoma (or cholangiolocellular carcinoma) than non-SJ patients. Chronic SJ was an independent adverse prognostic factor for survival after hepatic resection in HCC patients.

Entities:  

Mesh:

Year:  2009        PMID: 19771467     DOI: 10.1007/s00268-009-0228-7

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  21 in total

Review 1.  Liver disease in Egypt: hepatitis C superseded schistosomiasis as a result of iatrogenic and biological factors.

Authors:  G Thomas Strickland
Journal:  Hepatology       Date:  2006-05       Impact factor: 17.425

Review 2.  A historical view of schistosomiasis japonica in the Chikugo river basin. What can we learn from autopsy?

Authors:  Toshiro Nakashima; Masayoshi Kage; Mizuki Hirata
Journal:  Parasitol Int       Date:  2003-12       Impact factor: 2.230

3.  Primary liver cancer coincident with Schistosomiasis japonica. A study of 24 necropsies.

Authors:  T Nakashima; K Okuda; M Kojiro; K Sakamoto; Y Kubo
Journal:  Cancer       Date:  1975-10       Impact factor: 6.860

Review 4.  Schistosomiasis japonica: a vanishing endemic in Japan.

Authors:  K Kitani; M Iuchi
Journal:  J Gastroenterol Hepatol       Date:  1990 Mar-Apr       Impact factor: 4.029

5.  A case-control study on liver cancer with special emphasis on the possible aetiological role of schistosomiasis.

Authors:  Y Inaba; N Maruchi; M Matsuda; N Yoshihara; S Yamamoto
Journal:  Int J Epidemiol       Date:  1984-12       Impact factor: 7.196

6.  Clinical, virological and histopathological features: long-term follow-up in patients with chronic hepatitis C co-infected with S. mansoni.

Authors:  S Kamal; M Madwar; L Bianchi; A E Tawil; R Fawzy; T Peters; J W Rasenack
Journal:  Liver       Date:  2000-07

Review 7.  Imaging diagnosis of schistosomiasis japonica--the use in Japan and application for field study in the present endemic area.

Authors:  Hiroshi Ohmae; Orlando S Sy; Yuichi Chigusa; Gerundio P Portillo
Journal:  Parasitol Int       Date:  2003-12       Impact factor: 2.230

8.  Cholangiocarcinoma coincident with schistosomiasis japonica.

Authors:  Hideaki Andoh; Ouki Yasui; Toshiaki Kurokawa; Tsutomu Sato
Journal:  J Gastroenterol       Date:  2004-01       Impact factor: 7.527

Review 9.  Parasite infection and cancer: with special emphasis on Schistosoma japonicum infections (Trematoda). A review.

Authors:  A Ishii; H Matsuoka; T Aji; N Ohta; S Arimoto; Y Wataya; H Hayatsu
Journal:  Mutat Res       Date:  1994-03-01       Impact factor: 2.433

10.  Hepatoma formation in ddY mice with chronic schistosomiasis japonica.

Authors:  T Amano; T Oshima
Journal:  Jpn J Cancer Res       Date:  1988-02
View more
  2 in total

1.  Pseudotumoral form of neuroschistosomiasis: report of three cases in Ganzi, China.

Authors:  Heng Wan; Hayashi Masataka; Li-Ping Zhang; De-Fu Zheng
Journal:  Am J Trop Med Hyg       Date:  2012-02       Impact factor: 2.345

2.  Risk factors for hilar cholangiocarcinoma: a case-control study in China.

Authors:  Wen-Ke Cai; Hui Sima; Ben-Dong Chen; Guang-Shun Yang
Journal:  World J Gastroenterol       Date:  2011-01-14       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.